Bleeding that returns after 12 months without a period is classified as postmenopausal bleeding, and it should always be evaluated by a doctor. The good news: roughly 90% of women who experience it do not have cancer. But because about 9% to 12% of cases are linked to endometrial cancer, no episode of postmenopausal bleeding should be ignored or written off as a “late period.”
Why 12 Months Is the Cutoff
Menopause is officially defined as 12 consecutive months with no menstrual period. Once you’ve crossed that threshold, your ovaries have largely stopped releasing eggs and producing the cycling hormones that build and shed your uterine lining each month. Any bleeding that shows up after that point isn’t a normal period restarting. It’s coming from a different source, and identifying that source matters.
The Most Common Cause: Tissue Thinning
The single most frequent reason for postmenopausal bleeding is atrophy, a thinning of the uterine lining or vaginal walls. After menopause, estrogen levels drop sharply. Without estrogen to maintain it, the tissue lining your uterus becomes fragile and paper-thin. With so little cushioning, the inner walls of the uterus rub against each other, creating tiny surface erosions and low-grade inflammation. That chronic irritation can cause light spotting or bleeding that looks alarming but is not dangerous on its own.
The same thinning process happens in the vaginal walls. Vaginal atrophy can cause bleeding after intercourse or even spontaneously, and it’s easy to mistake for uterine bleeding. Your doctor can usually tell the difference during an exam.
Polyps and Fibroids
Endometrial polyps are small, typically noncancerous growths on the uterine lining. They’re common after menopause. In one study of 481 postmenopausal women found to have polyps, about half had no symptoms at all, while the other half experienced bleeding. In women without bleeding, the vast majority of polyps (nearly 94%) were benign. In women with bleeding, the malignancy rate was higher but still relatively low at about 7%. Polyps that cause bleeding are more likely to need removal and testing than those found incidentally.
Fibroids, particularly those that grow just beneath the uterine lining (called submucosal fibroids), can also trigger postmenopausal bleeding. These are less common than polyps but follow a similar pattern: they irritate the lining and cause irregular spotting or heavier bleeding.
Hormone Therapy as a Trigger
If you’re taking hormone replacement therapy (HRT) for menopause symptoms, breakthrough bleeding is a well-known side effect, especially in the first several months. The estrogen dose itself influences how likely you are to bleed. An imbalanced progestogen dose can change the structure of blood vessels in the uterine lining, making them more prone to leaking. This type of bleeding often settles down as your body adjusts, but it still needs to be reported to your prescriber so they can rule out other causes and adjust your regimen if needed.
The Cancer Connection
About 90% of women who develop endometrial cancer experience postmenopausal bleeding as their first symptom. That’s actually useful, because it means the cancer tends to announce itself early, when it’s most treatable. Looking at it from the other direction, about 9% of all women who report postmenopausal bleeding turn out to have endometrial cancer. That number rises to roughly 12% when you exclude women whose bleeding is explained by hormone therapy. Those odds are low enough to be reassuring but high enough that every case warrants investigation.
What Your Doctor Will Do
The evaluation is straightforward and usually starts with one of two tests. The first option is a transvaginal ultrasound, where a small probe measures the thickness of your uterine lining. If your lining measures 4 millimeters or less, the chance of endometrial cancer is extremely low, with a negative predictive value above 99%. In that case, no biopsy is typically needed unless bleeding continues.
The second option is an endometrial biopsy, where a thin tube is inserted through the cervix to collect a small tissue sample. This is often done right in the office. According to the American College of Obstetricians and Gynecologists, either test is a reasonable first step. You don’t need both at the outset. Women at higher risk for endometrial cancer based on their history or the pattern of bleeding are more likely to go straight to biopsy.
If the ultrasound can’t get a clear view of the lining, or if the biopsy doesn’t collect enough tissue for a diagnosis, follow-up options include a saline-infusion sonogram (which uses fluid to get a better ultrasound image) or hysteroscopy, where a tiny camera is guided into the uterus. The key principle is that persistent or recurrent bleeding always needs further evaluation, even if the first round of tests came back normal. Rare types of endometrial cancer can exist behind a lining that measures less than 3 millimeters, so repeat bleeding should never be dismissed.
What You Should Do Next
Track the bleeding. Note when it started, how heavy it is (spotting versus flow), whether it followed intercourse, and whether it’s a single episode or recurring. This information helps your doctor decide which test to start with. Don’t wait to see if it happens again before making an appointment. A single episode of bleeding after a year without periods is enough to justify evaluation.
Most women who go through this process get reassuring results. Atrophy, polyps, and hormone-related bleeding account for the large majority of cases and are all manageable. But the only way to know for certain is to get checked, and the sooner you do, the more options you have if something more serious is found.